Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen
Objectives: The optimal antiretroviral therapy for patients with the M184V/I mutation is not known. The primary objective of this study was to determine the efficacy of various antiretroviral therapies in patients with HIV and the M184V/I mutation based on the number of active antiretroviral agents....
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-09-01
|
| Series: | SAGE Open Medicine |
| Online Access: | https://doi.org/10.1177/2050312120960570 |